Announced Wed, 17 Sept · 18:25 IST

The Voting result and Scrutinizer Report for the remote and e-voting facility during the 32nd Annual General Meeting of the company held on 16.09.2025

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Choksi Laboratories held its 32nd Annual General Meeting on 16 September 2025 via video conferencing, where 4,118 shareholders were on the record date. Four resolutions were put to vote and all were approved with overwhelming majority. The resolutions included adoption of audited financial statements for FY ended March 31, 2025 (99.93% in favor), re-appointment of Mrs. Stela Choksi as Director retiring by rotation (99.91% in favor), re-appointment of Mr. Vyangesh Choksi as Whole-Time Director via special resolution (99.93% in favor), and appointment of M/s Surabhi Agrawal & Associates as Secretarial Auditor (99.93% in favor). Only 31.67% of outstanding shares (22,05,709 votes) were polled, with promoters voting 99.95% of their holdings while public non-institutional participation was just 0.29%.

Likely market impact

All routine AGM resolutions passed comfortably with near-unanimous support, reflecting smooth governance with no shareholder dissent of consequence. Low public voting turnout (only 0.29% of public non-institutional shares) means outcomes were driven almost entirely by promoter votes (~31.5% of total equity), which is typical for a closely-held small-cap company.